- Home
- PGEN vs FOF Comparison
PGEN vs FOF Comparison
Compare PGEN & FOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- FOF
- Stock Information
- Founded
- PGEN 1998
- FOF 2006
- Country
- PGEN United States
- FOF United States
- Employees
- PGEN N/A
- FOF N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- FOF Investment Managers
- Sector
- PGEN Health Care
- FOF Finance
- Exchange
- PGEN Nasdaq
- FOF Nasdaq
- Market Cap
- PGEN 344.0M
- FOF 341.7M
- IPO Year
- PGEN N/A
- FOF N/A
- Fundamental
- Price
- PGEN $1.53
- FOF $11.33
- Analyst Decision
- PGEN Strong Buy
- FOF
- Analyst Count
- PGEN 4
- FOF 0
- Target Price
- PGEN $7.33
- FOF N/A
- AVG Volume (30 Days)
- PGEN 1.4M
- FOF 58.7K
- Earning Date
- PGEN 05-13-2025
- FOF 01-01-0001
- Dividend Yield
- PGEN N/A
- FOF 9.07%
- EPS Growth
- PGEN N/A
- FOF N/A
- EPS
- PGEN N/A
- FOF N/A
- Revenue
- PGEN $3,925,000.00
- FOF N/A
- Revenue This Year
- PGEN $189.12
- FOF N/A
- Revenue Next Year
- PGEN $1,093.07
- FOF N/A
- P/E Ratio
- PGEN N/A
- FOF N/A
- Revenue Growth
- PGEN N/A
- FOF N/A
- 52 Week Low
- PGEN $0.65
- FOF $9.59
- 52 Week High
- PGEN $2.17
- FOF $11.75
- Technical
- Relative Strength Index (RSI)
- PGEN 52.21
- FOF 44.44
- Support Level
- PGEN $1.33
- FOF $11.14
- Resistance Level
- PGEN $1.49
- FOF $11.54
- Average True Range (ATR)
- PGEN 0.14
- FOF 0.49
- MACD
- PGEN 0.02
- FOF 0.02
- Stochastic Oscillator
- PGEN 95.45
- FOF 52.46
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About FOF Cohen & Steers Closed-End Opportunity Fund Inc.
Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. Its investment objective is to achieve a total return, consisting of high current income and potential capital appreciation.